Related Experiment Video
Updated: Dec 11, 2025

Use of Bisection to Reduce Mitochondrial DNA in the Bovine Oocyte
Published on: July 6, 2022
Mitochondrial Genetic Drift after Nuclear Transfer in Oocytes
Mitsutoshi Yamada1, Kazuhiro Akashi1, Reina Ooka1
1Department of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan.
Abstract:
Mitochondria are energy-producing intracellular organelles containing their own genetic material in the form of mitochondrial DNA (mtDNA), which codes for proteins and RNAs essential for mitochondrial function. Some mtDNA mutations can cause mitochondria-related diseases. Mitochondrial diseases are a heterogeneous group of inherited disorders with no cure, in which mutated mtDNA is passed from mothers to offspring via maternal egg cytoplasm. Mitochondrial replacement (MR) is a genome transfer technology in which mtDNA carrying disease-related mutations is replaced by presumably disease-free mtDNA. This therapy aims at preventing the transmission of known disease-causing mitochondria to the next generation. Here, a proof of concept for the specific removal or editing of mtDNA disease-related mutations by genome editing is introduced. Although the amount of mtDNA carryover introduced into human oocytes during nuclear transfer is low, the safety of mtDNA heteroplasmy remains a concern. This is particularly true regarding donor-recipient mtDNA mismatch (mtDNA-mtDNA), mtDNA-nuclear DNA (nDNA) mismatch caused by mixing recipient nDNA with donor mtDNA, and mtDNA replicative segregation. These conditions can lead to mtDNA genetic drift and reversion to the original genotype. In this review, we address the current state of knowledge regarding nuclear transplantation for preventing the inheritance of mitochondrial diseases.
Insights
Mitochondrial replacement therapy aims to prevent inherited mitochondrial diseases by replacing mutated mitochondrial DNA (mtDNA). Genome editing offers a new approach to remove or correct mtDNA mutations, but safety concerns like heteroplasmy require further investigation.
Area of Science:
- Cell Biology
- Genetics
- Reproductive Medicine
Background:
- Mitochondria generate cellular energy and possess their own DNA (mtDNA).
- Mutations in mtDNA cause inherited mitochondrial diseases, passed from mothers to offspring.
- Current treatments for mitochondrial diseases are limited, necessitating preventative strategies.
Purpose of the Study:
- To review the current knowledge on nuclear transplantation for preventing the inheritance of mitochondrial diseases.
- To introduce genome editing as a potential method for removing or editing disease-related mtDNA mutations.
- To address safety concerns associated with mitochondrial replacement therapy.
Main Methods:
- Review of existing literature on mitochondrial replacement and nuclear transplantation.
- Discussion of genome editing techniques for mtDNA mutation correction.
- Analysis of safety concerns including mtDNA heteroplasmy and genetic drift.
Main Results:
- Mitochondrial replacement is a genome transfer technology aimed at preventing transmission of mutated mtDNA.
- Genome editing offers a proof of concept for specific removal or editing of mtDNA mutations.
- Safety concerns regarding mtDNA heteroplasmy, donor-recipient mismatch, and replicative segregation persist.
Conclusions:
- Nuclear transplantation is a key strategy for preventing the inheritance of mitochondrial diseases.
- Genome editing presents a novel approach for correcting mtDNA mutations, but requires further safety validation.
- Addressing challenges like heteroplasmy and genetic drift is crucial for the clinical application of these technologies.
Related Concept Videos
Animal Mitochondrial Genetics
Mutation, Gene Flow, and Genetic Drift
Genetic Drift
Export of Mitochondrial and Chloroplast Genes
Non-nuclear Inheritance
Meiosis vs. Mitosis
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...

